Tatsuya Okuno

3.1k total citations · 1 hit paper
64 papers, 1.7k citations indexed

About

Tatsuya Okuno is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Oncology. According to data from OpenAlex, Tatsuya Okuno has authored 64 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Pulmonary and Respiratory Medicine, 28 papers in Surgery and 20 papers in Oncology. Recurrent topics in Tatsuya Okuno's work include Gastric Cancer Management and Outcomes (25 papers), Esophageal Cancer Research and Treatment (20 papers) and Lung Cancer Treatments and Mutations (13 papers). Tatsuya Okuno is often cited by papers focused on Gastric Cancer Management and Outcomes (25 papers), Esophageal Cancer Research and Treatment (20 papers) and Lung Cancer Treatments and Mutations (13 papers). Tatsuya Okuno collaborates with scholars based in Japan, United States and Australia. Tatsuya Okuno's co-authors include Kinji Ohno, Akihide Shibata, Takeshi Azuma, Akira Okamoto, Masaaki Hirayama, Yoshiro Fujisawa, Hirokazu Tsuji, Koji Nomoto, Satoru Hasegawa and Takashi Asahara and has published in prestigious journals such as Journal of Clinical Oncology, Genes & Development and Blood.

In The Last Decade

Tatsuya Okuno

60 papers receiving 1.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Intestinal Dysbiosis and Lowered Serum Lipopolysaccharide-Binding Protein in Parkinson’s Disease

2015 387 citations Satoru Hasegawa, Hirokazu Tsuji et al. PLoS ONE profile →

Peers

Countries citing papers authored by Tatsuya Okuno

Since Specialization

Citations

This map shows the geographic impact of Tatsuya Okuno's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tatsuya Okuno with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tatsuya Okuno more than expected).

Fields of papers citing papers by Tatsuya Okuno

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tatsuya Okuno. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tatsuya Okuno. The network helps show where Tatsuya Okuno may publish in the future.

Co-authorship network of co-authors of Tatsuya Okuno

This figure shows the co-authorship network connecting the top 25 collaborators of Tatsuya Okuno. A scholar is included among the top collaborators of Tatsuya Okuno based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tatsuya Okuno. Tatsuya Okuno is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Ramucirumab plus FOLFIRI as second-line treatment for patients with RAS wild-type metastatic colorectal cancer previously treated with anti-EGFR antibody: JACCRO CC-16 2023 ·ESMO Open ·Hisateru Yasui, (unknown), Masato Nakamura, Takashi Sagawa, Takanori Watanabe, Kozo Kataoka, Dai Manaka, (unknown), Naoya Akazawa, Tatsuya Okuno, Takaya Shimura, Manabu Shiozawa, Yu Sunakawa, Hirofumi Ota, Masahito Kotaka, Hiroomi Okuyama, Masahiro Takeuchi, Wataru Ichikawa, Masashi Fujii, Akihito Tsuji	2
2	Early tumor shrinkage and depth of response in patients with metastatic esophageal cancer treated with 2-weekly docetaxel combined with cisplatin plus fluorouracil: an exploratory analysis of the JCOG0807 2022 ·Esophagus ·Takashi Ura, Shuichi Hironaka, Yasuhiro Tsubosa, Junki Mizusawa, Ken Kato, Takahiro Tsushima, (unknown), Keisho Chìn, Akihisa Tomori, Tatsuya Okuno, Hisayuki Matsushita, Takashi Kojima, Yuichiro� Doki, Hitoshi Kusaba, Kazumasa Fujitani, (unknown), Yuko Kitagawa	6
3	Nivolumab-Induced Hemophilia A Presenting as Gastric Ulcer Bleeding in a Patient With NSCLC 2018 ·Journal of Thoracic Oncology ·Ryoji Kato, Hidetoshi Hayashi, (unknown), (unknown), (unknown), Hiroto Ueda, Tatsuya Okuno, Hisato Kawakami, Itaru Matsumura, Masatoshi Kudo, Kazuhiko Nakagawa	20
4	Phase III study comparing triplet chemotherapy with S-1 and cisplatin plus docetaxel versus doublet chemotherapy with S-1 and cisplatin for advanced gastric cancer (JCOG1013). 2018 ·Journal of Clinical Oncology ·Yasuhide Yamada, Narikazu Boku, Junki Mizusawa, Satoru Iwasa, Shigenori Kadowaki, Norisuke Nakayama, Mizutomo Azuma, Takeshi Sakamoto, Kohei Shitara, Tatsuya Okuno, Keisho Chìn, Akira Nozaki, Masaki Nakamura, Hiroki Hara, Hiroshi Katayama, Haruhiko Fukuda, Takaki Yoshikawa, Takeshi Sano, Mitsuru Sasako, Masanori Terashima	10
5	Clinical characteristics of Japanese patients with epithelioid hemangioendothelioma: a multicenter retrospective study 2018 ·BMC Cancer ·Satoshi Shiba, Hiroshi Imaoka, Kazuhiko Shioji, Eiichiro Suzuki, Shigeru Horiguchi, Takeshi Terashima, Yasushi Kojima, Tatsuya Okuno, Yasutaka Sukawa, Kunihiko Tsuji, Kumiko Umemoto, Akinori Asagi, Akiko Todaka, Makoto Ueno, Masafumi Ikeda, Chigusa Morizane, Junji Furuse	36
6	Esophageal stenosis and the Glasgow Prognostic Score as independent factors of poor prognosis for patients with locally advanced unresectable esophageal cancer treated with chemoradiotherapy (exploratory analysis of JCOG0303) 2017 ·International Journal of Clinical Oncology ·Tatsuya Okuno, Masashi Wakabayashi, Ken Kato, Masayuki Shinoda, Hiroshi Katayama, Hiroyasu Igaki, Yasuhiro Tsubosa, Takashi Kojima, Hiroshi Okabe, Yusuke Kimura, Tatsuyuki Kawano, Shin‐ichi Kosugi, Yasushi Toh, Hoichi Kato, Kenichi Nakamura, Haruhiko Fukuda, Satoshi Ishikura, Nobutoshi Ando, Yuko Kitagawa	31
7	Genetic Background of Chronic Active Epstein-Barr Virus Disease 2017 ·Blood ·Yusuke Okuno, Takayuki Murata, Yoshitaka Sato, Hideki Muramatsu, Norihiro Murakami, Tatsuya Okuno, Kenichi Yoshida, Yoshinori Ito, Akihisa Sawada, Koichi Ohshima, Yuichi Shiraishi, Kenichi Chiba, Hiroko Tanaka, Satoru Miyano, Yoshiyuki Takahashi, Seiji Kojima, Seishi Ogawa, Hiroshi Kimura	4
8	Intestinal Dysbiosis and Lowered Serum Lipopolysaccharide-Binding Protein in Parkinson’s Disease breakdown → 2015 ·PLoS ONE ·Satoru Hasegawa, (unknown), Hirokazu Tsuji, Tatsuya Okuno, Takashi Asahara, Koji Nomoto, Akihide Shibata, Yoshiro Fujisawa, Tomomi Minato, Akira Okamoto, Kinji Ohno, Masaaki Hirayama	387
9	Position-specific binding of FUS to nascent RNA regulates mRNA length 2015 ·Genes & Development ·Akio Masuda, Jun‐ichi Takeda, Tatsuya Okuno, Takaaki Okamoto, Bisei Ohkawara, Mikako Ito, Shinsuke Ishigaki, Gen Sobue, Kinji Ohno	91
10	A missense mutation in domain III in HSPG2 in Schwartz–Jampel syndrome compromises secretion of perlecan into the extracellular space 2015 ·Neuromuscular Disorders ·Satoshi Iwata, Mikako Ito, Tomohiko Nakata, Yoichiro Noguchi, Tatsuya Okuno, Bisei Ohkawara, Akio Masuda, Tomohide Goto, Masanori Adachi, Hitoshi Osaka, Risa Nonaka, Eri Arikawa‐Hirasawa, Kinji Ohno	15
11	Lansoprazole Upregulates Polyubiquitination of the TNF Receptor-Associated Factor 6 and Facilitates Runx2-mediated Osteoblastogenesis 2015 ·EBioMedicine ·Kenichi Mishima, Hiroshi Kitoh, Bisei Ohkawara, Tatsuya Okuno, Mikako Ito, Akio Masuda, Naoki Ishiguro, Kinji Ohno	18
12	Congenital myasthenic syndrome in Japan: Ethnically unique mutations in muscle nicotinic acetylcholine receptor subunits 2014 ·Neuromuscular Disorders ·Yoshiteru Azuma, Tomohiko Nakata, Motoki Tanaka, Xin‐Ming Shen, Mikako Ito, Satoshi Iwata, Tatsuya Okuno, Yoshiko Nomura, N Ando, Keiko Ishigaki, Bisei Ohkawara, Akio Masuda, Jun Natsume, Seiji Kojima, Masahiro Sokabe, Kinji Ohno	19
13	TNF-α -857C>T Genotype is Predictive of Clinical Response after Treatment with Definitive 5-Fluorouracil/cisplatin-based Chemoradiotherapy in Japanese Patients with Esophageal Squamous Cell Carcinoma 2013 ·International Journal of Medical Sciences ·H. Omatsu, Akiko Kuwahara, Motohiro Yamamori, Megumi Fujita, Tatsuya Okuno, Ikuya Miki, Takao Tamura, Kohshi Nishiguchi, Noboru Okamura, Tsutomu Nakamura, Takeshi Azuma, Takeshi Hirano, Koichiro Ozawa, Midori Hirai	6
14	VEGF -634C/G Genotype is Predictive of Long-term Survival after Treatment with a Definitive 5-Fluorouracil/cisplatin-based Chemoradiotherapy in Japanese Patients with Esophageal Squamous Cell Carcinoma 2012 ·International Journal of Medical Sciences ·Takao Tamura, Akiko Kuwahara, Motohiro Yamamori, Kohshi Nishiguchi, Tsutomu Nakamura, Tatsuya Okuno, Ikuya Miki, Yuki Manabe, Toshiyuki Sakaeda	15
15	Effects of Bolus Injection of 5-Fluorouracil on Steady-State Plasma Concentrations of 5-Fluorouracil in Japanese Patients with Advanced Colorectal Cancer 2011 ·International Journal of Medical Sciences ·Takao Tamura, Akiko Kuwahara, Kaori Kadoyama, Motohiro Yamamori, Kohshi Nishiguchi, (unknown), (unknown), Naoko Chayahara, Tatsuya Okuno, Ikuya Miki, (unknown), Toshiyuki Sakaeda	11
16	Effects of plasma concentrations of 5-fluorouracil on long-term survival after treatment with a definitive 5-fluorouracil/cisplatin-based chemoradiotherapy in Japanese patients with esophageal squamous cell carcinoma 2011 ·Journal of Experimental & Clinical Cancer Research ·Akiko Kuwahara, Motohiro Yamamori, Kaori Kadoyama, Kohshi Nishiguchi, Tsutomu Nakamura, Ikuya Miki, Takao Tamura, Tatsuya Okuno, H. Omatsu, Toshiyuki Sakaeda	5
17	TNFRSF1B A1466G genotype is predictive of clinical efficacy after treatment with a definitive 5-fluorouracil/cisplatin-based chemoradiotherapy in Japanese patients with esophageal squamous cell carcinoma 2010 ·Journal of Experimental & Clinical Cancer Research ·Akiko Kuwahara, Motohiro Yamamori, Megumi Fujita, Tatsuya Okuno, Takao Tamura, Kaori Kadoyama, Noboru Okamura, Tsutomu Nakamura, Toshiyuki Sakaeda	22
18	Favorable Genetic Polymorphisms Predictive of Clinical Outcome of Chemoradiotherapy for Stage II/III Esophageal Squamous Cell Carcinoma in Japanese 2007 ·American Journal of Clinical Oncology ·Tatsuya Okuno, Takao Tamura, Motohiro Yamamori, Naoko Chayahara, Toshio Yamada, Ikuya Miki, Noboru Okamura, (unknown), Daisuke Shirasaka, Nobuo Aoyama, Tsutomu Nakamura, Katsuhiko Okumura, Takeshi Azuma, Masato Kasuga, Toshiyuki Sakaeda	27
19	TREATMENT RESULTS OF GLOTTIC AND HYPOPHARYNGEAL CANCERS-FROM THE VIEWPOINT OF HEAD AND NECK SURGEON- 2006 ·Toukeibu Gan ·Ken‐ichi Nibu, Naoki Otsuki, Miki Saito, Ryohei Sasaki, (unknown), Daisuke Shirasaka, Tatsuya Okuno	1
20	Early colon cancers detected by FDG-pet: a report of two cases with immunohistochemical investigation. 2004 ·PubMed ·Tatsuya Okuno, Kuang I. Fu, Yasushi Sano, Takayuki Yoshino, Kouji Murakami, Atsushi Ochiai, Shigeaki Yoshida	3

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact